Empagliflozin + Sitagliptin
Information about Empagliflozin + Sitagliptin
Empagliflozin + Sitagliptin Uses
Empagliflozin+Sitagliptin is used in the treatment of type 2 diabetes mellitus.
How Empagliflozin + Sitagliptin works
Empagliflozin + Sitagliptin is a combination of two medicines, empagliflozin and sitagliptin, which help control blood sugar levels in people with type 2 diabetes. Empagliflozin works by helping the kidneys remove extra sugar from the body through urine. Sitagliptin helps the body release more insulin when blood sugar is high and reduces the amount of sugar made by the liver. By working in different ways, these two medicines complement each other and provide better blood sugar control than either medicine alone.
Common side effects of Empagliflozin + Sitagliptin
Urinary tract infection, Fungal infection, Upper respiratory tract infection, Headache
Medicine brands for Empagliflozin + Sitagliptin
Empatrol-SAristo Pharmaceuticals Pvt Ltd
₹1731 variant(s)
Glura EEris Lifesciences Limited
₹159 to ₹1682 variant(s)
Alsita-EAlkem Laboratories Ltd
₹149 to ₹1582 variant(s)
Gibtulio-SLupin Ltd
₹168 to ₹1782 variant(s)
Empajoy-SMacleods Pharmaceuticals Pvt Ltd
₹99 to ₹1212 variant(s)
Empayug SInuen Healthcare Pvt Ltd
₹1861 variant(s)
Empashield-SLa Renon Healthcare Pvt Ltd
₹167 to ₹1862 variant(s)
Empazio STorrent Pharmaceuticals Ltd.
₹185 to ₹2062 variant(s)
Empaglyn SZydus Healthcare Limited
₹150 to ₹1962 variant(s)
Empagreat-SMankind Pharma Ltd
₹102 to ₹1262 variant(s)
Expert advice for Empagliflozin + Sitagliptin
- Let your doctor know if you are taking any other diabetes medicines with Empagliflozin + Sitagliptin, especially insulin or sulfonylureas, to avoid the risk of hypoglycemia (low blood sugar).
- Do not stop taking Empagliflozin + Sitagliptin suddenly without consulting your doctor, even if you feel well or your blood sugar improves.
- If you plan to undergo surgery or any major procedure, inform your doctor in advance, as temporary discontinuation may be advised.
- Empagliflozin + Sitagliptin is not suitable for people with type 1 diabetes or the treatment of diabetic ketoacidosis.